First Bight Ventures

firstbight.com

VCMatch tracks First Bight Ventures as an investor focused on Biotech, Climate/Cleantech, and Manufacturing companies, Seed and Series A rounds, and United States, Houston, Tx, and Global markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A

Focus Areas

Biotech, Climate/Cleantech, Manufacturing

Geography

United States, Houston, TX, and Global

Investment Thesis

First Bight invests in ‘nature’s chemistry’ and early-stage biomanufacturing to replace petrochemical inputs with bio-based alternatives, believing biomanufacturing can deliver cleaner ingredients at industrial scale and reshape large industries. They target investments where strong, patented science meets early commercial traction and where the firm can actively de-risk scale-up by providing strategic, hands-on support, non-dilutive capital access, and operational expertise to generate predictable, high-return outcomes.

Is First Bight Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

First Bight Ventures is most relevant for founders raising Seed and Series A rounds in Biotech, Climate/Cleantech, Manufacturing, and Hardware, especially across United States, Houston, TX, and Global.

Focus statement

We invest in companies driving the bioeconomy forward, specifically seed through Series A in sustainable chemicals, industrial biomanufacturing, agrochemicals, and enabling hardware & software — with a preference for financing 'engineering risk' once a proof-of-concept exists.

Value Add

Laser focus exclusively on biomanufacturing and sustainable chemicals (industrial chemicals, agrochemicals, hardware & software).
Active, lead investor that 'writes first checks' and seeks board seats — not silent capital.
Explicit preference to finance 'engineering risk' rather than market or technical risk: 'We invest from seed to Series A, and like to finance engineering risk. We do not want to finance market risks, technical risks, etc.'
Ecosystem builder with operational programs like the 'BioWell Accelerator' and 'Scalable Infrastructure' to help companies generate samples, find customers, and optimize ops.
Capital advantage through 'Access to federal grants and non-dilutive programs that extend runway.'
Geographic and industrial advantage based in Houston — 'Sitting at the crossroads of energy, logistics, and life-science talent.'
Explicit commercial return targets and go-to-scale metrics: looks for 'pathway to $100 M+ in annual revenue' and 'Minimum 20× return potential and a clear route to $1 B+ valuation at exit.'